Cargando…

Intravenous thrombolysis in acute ischemic stroke after antagonization of unfractionated heparin with protamine: case series and systematic review of literature

BACKGROUND AND AIMS: Intravenous thrombolysis (IVT) is standard of care for disabling acute ischemic stroke (AIS) within a time window of ⩽ 4.5 h. Some AIS patients cannot be treated with IVT due to limiting contraindications, including heparin usage in an anticoagulating dose within the past 24 h o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kneer, Katharina, Adeyemi, Adedolapo Kamaldeen, Sartor-Pfeiffer, Jennifer, Wilke, Vera, Blum, Corinna, Ziemann, Ulf, Poli, Sven, Mengel, Annerose, Feil, Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880584/ https://www.ncbi.nlm.nih.gov/pubmed/36710724 http://dx.doi.org/10.1177/17562864221149249

Ejemplares similares

Effects of Melatonin Administration on Post-Stroke Delirium in Patients with Intracerebral Hemorrhage
por: Siokas, Vasileios, et al.
Publicado: (2023)

Rescue Revascularisation in Acute Internal Carotid Artery Occlusion with a Super Extended Time Window of More than 48 hours
por: Berger, Katharina, et al.
Publicado: (2022)

Regional computed tomography perfusion deficits in patients with hypoglycemia: two case reports
por: Sartor-Pfeiffer, Jennifer, et al.
Publicado: (2022)

Rapid Diagnosis of Central Nervous System Scedosporiosis by Specific Quantitative Polymerase Chain Reaction Applied to Formalin-Fixed, Paraffin-Embedded Tissue
por: Lauerer, Robert J., et al.
Publicado: (2021)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Minor stroke in large vessel occlusion: A matched analysis of patients from the German Stroke Registry–Endovascular Treatment (GSR‐ET) and patients from the Safe Implementation of Treatments in Stroke–International Stroke Thrombolysis Register (SITS‐ISTR)
por: Feil, Katharina, et al.
Publicado: (2022)

Thrombolysis in Stroke With Unknown Onset Based on Non‐Contrast Computerized Tomography (TRUST CT)
por: Sykora, Marek, et al.
Publicado: (2020)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
por: Garcia, Flávio Luís, et al.
Publicado: (2015)

Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments
por: Davenport, Andrew
Publicado: (2012)

Impact of COVID-19 on monitoring of therapeutic unfractionated heparin
por: Adie, Sarah K., et al.
Publicado: (2020)

Quantitative Analysis of Impurities in Unfractionated Heparin of Bovine Origin
por: Workman, Wesley E., et al.
Publicado: (2020)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

Resistance to unfractionated heparin in the ICU: evaluation and management options
por: Levy, Jerrold H., et al.
Publicado: (2023)

No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke
por: Laichinger, Kornelia, et al.
Publicado: (2023)

Comparison of Risk Factors, Safety, and Efficacy Outcomes of Mechanical Thrombectomy in Posterior vs. Anterior Circulation Large Vessel Occlusion
por: Mbroh, Joshua, et al.
Publicado: (2021)

Amantadine for NeuroenhaNcement in acutE patients Study - a protocol for a prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES)
por: Hofmann, Anna, et al.
Publicado: (2023)

Protamine/heparin optical nanosensors based on solvatochromism
por: Soda, Yoshiki, et al.
Publicado: (2021)

The Role of Vascular Risk Factors in Post-Stroke Delirium: A Systematic Review and Meta-Analysis
por: Siokas, Vasileios, et al.
Publicado: (2022)

Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome
por: Seaman, Craig D., et al.
Publicado: (2020)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
por: McGarry, Lisa J, et al.
Publicado: (2006)

Opposition: Unfractionated heparin should no longer be used in the catheterization laboratory
por: Kim, Moo Hyun, et al.
Publicado: (2014)

Recent Progress on Heparin–Protamine Particles for Biomedical Application
por: Hata, Yuuki, et al.
Publicado: (2022)

Low-Molecular-Weight Heparin and Unfractionated Heparin Decrease Th-1, 2, and 17 Expressions
por: Huang, Jing-Ning, et al.
Publicado: (2014)

Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin
por: Maharaj, Satish, et al.
Publicado: (2018)

Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022)

Distinct Effects of Unfractionated Heparin versus Bivalirudin on Circulating Angiogenic Peptides
por: Kapur, Navin K., et al.
Publicado: (2012)

Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity
por: Li, Binghan, et al.
Publicado: (2016)

Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin
por: Kalaska, Bartlomiej, et al.
Publicado: (2015)

Individual variation in unfractionated heparin dosing after pediatric cardiac surgery
por: Hikino, Keiko, et al.
Publicado: (2020)

Validation of high concentrated thrombin time assay for unfractionated heparin monitoring
por: Apipongrat, Dollapak, et al.
Publicado: (2022)

Predicting Therapeutic Response to Unfractionated Heparin Therapy: Machine Learning Approach
por: Abdel-Hafez, Ahmad, et al.
Publicado: (2022)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
por: Amin, Alpesh, et al.
Publicado: (2023)

The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
por: Afshari, Daryoush, et al.
Publicado: (2015)

Applications and Implications of Heparin and Protamine in Tissue Engineering and Regenerative Medicine
por: Nemeno, Judee Grace E., et al.
Publicado: (2014)

Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate
por: Hogwood, John, et al.
Publicado: (2017)

A comparative study of dalteparin and unfractionated heparin in patients with unstable angina pectoris
por: Amane, Hanmant S., et al.
Publicado: (2011)

Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease
por: Nicholson, Tricia, et al.
Publicado: (2001)

Impact of nebulized unfractionated heparin and N-acetylcysteine in management of smoke inhalation injury
por: Elamin, E, et al.
Publicado: (2009)

Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery
por: Jia, Zaishen, et al.
Publicado: (2015)

Inhibition of Gastric Acid Secretion by Unfractionated and Low Molecular Weight Heparins in the Rat
por: Abdel Salam, Omar M.E., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_9i9l4colj84r4dte7eio3p8bcb